Edition:
United States

CombiMatrix Corp (CBMX.OQ)

CBMX.OQ on NASDAQ Stock Exchange Capital Market

7.95USD
23 Oct 2017
Change (% chg)

-- (--)
Prev Close
$7.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,313
52-wk High
$8.15
52-wk Low
$2.15

Latest Key Developments (Source: Significant Developments)

CombiMatrix sets record date and special stockholders meeting date regarding proposed merger
Monday, 25 Sep 2017 06:00am EDT 

Sept 25 (Reuters) - Combimatrix Corp :CombiMatrix sets record date and special stockholders meeting date regarding proposed merger with invitae.CombiMatrix Corp - ‍Special meeting of stockholders will be held on November 10, 2017​.CombiMatrix Corp - Merger has been unanimously approved by boards of directors of both companies.CombiMatrix Corp - Proposed merger is expected to close in Q4 of 2017.  Full Article

Stonepine Capital Management reports 9.96 pct passive stake in Combimatrix as of Aug 2
Wednesday, 9 Aug 2017 02:58pm EDT 

Aug 9 (Reuters) - Stonepine Capital Management LLC::Stonepine Capital Management Llc reports 9.96 percent passive stake in Combimatrix Corp as of August 2, 2017 - sec filling.  Full Article

Combimatrix Corp reports Q2 loss per share $0.13
Thursday, 3 Aug 2017 06:00am EDT 

Aug 3 (Reuters) - Combimatrix Corp :Combimatrix Corp reports second quarter 2017 financial and operating results.Q2 loss per share $0.13.Q2 revenue rose 36.5 percent to $4.2 million.  Full Article

Combimatrix to be acquired for $33 mln in Invitae common stock
Monday, 31 Jul 2017 04:58pm EDT 

July 31 (Reuters) - Combimatrix Corp :Combimatrix enters into merger agreement with Invitae Corporation to be acquired for $33 million in Invitae common stock.Deal for ‍$33 million of combined consideration​.Combimatrix Corp says merger has been approved by each company's board of directors.Combimatrix - ‍presently estimates Combimatrix price per share received by Combimatrix common stockholders would be between about $8.00 and $8.65​.  Full Article

CombiMatrix Q1 loss per share $0.19
Thursday, 4 May 2017 04:05pm EDT 

May 4 (Reuters) - CombiMatrix Corp ::CombiMatrix Corporation reports first quarter 2017 financial and operating results.Q1 loss per share $0.19.Q1 revenue rose 27 percent to $3.8 million.Q1 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S.Q1 revenue view $3.6 million -- Thomson Reuters I/B/E/S.  Full Article

Lipka Michael Andrew reports 6.1 pct passive stake in Combimatrix as of Feb 23- SEC filing
Friday, 3 Mar 2017 11:10am EST 

Combimatrix Corp:Lipka Michael Andrew reports 6.1 percent passive stake in Combimatrix Corp as of feb 23, 2017- SEC filing.  Full Article

CombiMatrix Corporation Q4 loss per share $0.22
Wednesday, 22 Feb 2017 04:05pm EST 

CombiMatrix Corporation : CombiMatrix Corporation reports 2016 fourth quarter and full year financial and operating results . Q4 loss per share $0.22 .Q4 revenue rose 32 percent to $3.5 million.  Full Article

Combimatrix reports agreement with Universal Labs
Wednesday, 10 Aug 2016 06:00am EDT 

Press Release : Combimatrix announces distribution agreement with universal diagnostic laboratories for miscarriage analysis testing .Combimatrix corp says terms of agreement were not disclosed.  Full Article

Combimatrix Reports Q2 loss per share $0.89
Wednesday, 3 Aug 2016 04:05pm EDT 

Combimatrix Corp : Q2 revenue rose 22 percent to $3.1 million . Combimatrix corporation reports second quarter 2016 financial and operating results .Q2 loss per share $0.89.  Full Article

CombiMatrix Corp prices $8 mln underwritten public offering
Monday, 21 Mar 2016 08:12am EDT 

CombiMatrix Corp:Says has priced a firm commitment underwritten public offering of 8,000 units of Series F convertible preferred stock.Offering is expected to close on or about March 24, 2016.Each unit consists of one share of Series F convertible preferred stock, which is convertible into 258.397875 shares of common stock at a conversion price of $3.87 per share.In total, the Series F convertible preferred stock is convertible into 2,067,183 shares of common stock, and the warrants are exercisable for 2,067,183 shares of common stock.Company will use part of the proceeds from this offering to repurchase and retire its Series E convertible preferred stock.  Full Article

BRIEF-CombiMatrix Corp says co's unit entered into Marketing and Laboratory Services Agreement with Invitae Corp and its unit

* CombiMatrix Corp - ‍on Sept 25, co's unit CombiMatrix Molecular Diagnostics Inc entered into marketing and laboratory services agreement with Invitae Corp and its unit